Pharmaceutical API Powder CAS 1392275-56-7 99% Tenofovir Alafenamide

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Gold Member Since 2022

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Number of Employees
1
Year of Establishment
2022-02-18
  • Pharmaceutical API Powder CAS 1392275-56-7 99% Tenofovir Alafenamide
  • Pharmaceutical API Powder CAS 1392275-56-7 99% Tenofovir Alafenamide
  • Pharmaceutical API Powder CAS 1392275-56-7 99% Tenofovir Alafenamide
  • Pharmaceutical API Powder CAS 1392275-56-7 99% Tenofovir Alafenamide
  • Pharmaceutical API Powder CAS 1392275-56-7 99% Tenofovir Alafenamide
  • Pharmaceutical API Powder CAS 1392275-56-7 99% Tenofovir Alafenamide
Find Similar Products
  • Overview
  • Product Description
  • Function
  • Application
  • Detailed Photos
  • Related product
  • Shipping
  • Payment
Overview

Basic Info.

Model NO.
MEI----99851
Suitable for
Elderly, Children, Adult
State
Solid
Purity
>99%
Mf
C21h29n6o5p.1/2 C4h4o4
MW
C21h29n6o5p.1/2 C4h4o4
Test Method
HPLC
Storage
Store Cool Dry Place
Market
Worldwide
CAS
1392275-56-7
Transport Package
Aluminium Foil Bag
Specification
99%
Trademark
Meister
Origin
China
Production Capacity
2000kg/Month

Product Description

Pharmaceutical API Powder CAS 1392275-56-7 99% Tenofovir Alafenamide
Pharmaceutical API Powder CAS 1392275-56-7 99% Tenofovir Alafenamide
Product Description

 

Product Name Pharmaceutical API Powder CAS 1392275-56-7 99% Tenofovir Alafenamide
Appearance powder
cas 379270-37-8
Assay 99%
Keywords Tenofovir Alafenamide , chemical Tenofovir Alafenamide ,powder Tenofovir Alafenamide 
Shelf Life 24 months when properly stored
Storage Keep in a cool, dry, dark location

Tenofovir alafenamide is a prodrug of tenofovir (T018500), which is a reverse transcriptase inhibitor used to treat HIV and hepatitis B

 
Function

Pharmaceutical raw materials; pharmaceutical chemicals; medical raw materials; chemical raw materials

 

Application

It acts as an inhibitor of janus kinase (JAK), blocking the subtypes JAK1 and JAK2. The drug is approved for use in the European Union and the United States. 

Detailed Photos

Pharmaceutical API Powder CAS 1392275-56-7 99% Tenofovir Alafenamide

 

Related product

Pharmaceutical API Powder CAS 1392275-56-7 99% Tenofovir Alafenamide

Shipping

Pharmaceutical API Powder CAS 1392275-56-7 99% Tenofovir Alafenamide

Payment

Pharmaceutical API Powder CAS 1392275-56-7 99% Tenofovir Alafenamide

 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier